Ocumension Therapeutics (1477.HK) Announces 2020 Annual Results Ocumension Therapeutics Mar 20, 2021 10:10 HKT/SGT Read More
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission Hua Medicine Mar 19, 2021 14:34 HKT/SGT Read More
애질렉스 바이오랩스, 춘계 바이오-유럽 2021에서 선도적인 면역분석법 및 면역생물학 서비스 선보여 Agilex Biolabs Mar 18, 2021 10:40 HKT/SGT Read More
Fujitsu Embarks on Joint Research with National Cancer Center Japan to Create New Services for Drug Development and Clinical Trials Fujitsu Ltd Mar 18, 2021 10:35 HKT/SGT Read More
DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders Eisai Mar 17, 2021 10:05 HKT/SGT Read More
Eisai: Anti-MTBR (Microtubule Binding Region) Tau Antibody E2814 is Selected on Clinical Study for Dominantly Inherited Alzheimer's Disease by Dian-Tu Eisai Mar 16, 2021 10:37 HKT/SGT Read More
エーザイ、DIAN-TUは優性遺伝アルツハイマー病に対する臨床試験において、抗MTBR(Microtubule binding region: 微小管結合領域)タウ抗体E2814を選定 Eisai Mar 16, 2021 09:00 JST Read More
Alvotech Completes Second Round of a US$100 Million Private Placement Alvotech Mar 15, 2021 17:38 HKT/SGT Read More